Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 17841 - 17860 out of 554157 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 1.2 g/20 mL injection, 20 mL vial | Solution concentrate for I.V. infusion 1200 mg in 20 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg/14 mL injection, 14 mL vial | Solution concentrate for I.V. infusion 840 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg/14 mL injection, 14 mL vial | Solution concentrate for I.V. infusion 840 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg/14 mL injection, 14 mL vial | Solution concentrate for I.V. infusion 840 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg/14 mL injection, 14 mL vial | Solution concentrate for I.V. infusion 840 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg/14 mL injection, 14 mL vial | Solution concentrate for I.V. infusion 840 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF05) atezolizumab (adm: P) | Tecentriq 840 mg/14 mL injection, 14 mL vial | Solution concentrate for I.V. infusion 840 mg in 14 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | RocheProductsPtyLtd |
| Australia | (L01FF06) cemiplimab (adm: P) | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab (adm: P) | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab (adm: P) | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF06) cemiplimab (adm: P) | Libtayo 350 mg/7 mL injection, 7 mL vial | Solution concentrate for I.V. infusion 350 mg in 7 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Squamous Cell | MEDISONPHARMAAUSTRALIAPTYLIMITED |
| Australia | (L01FF07) dostarlimab | Jemperli 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineAustraliaPtyLtd |
| Australia | (L01FF07) dostarlimab | Jemperli 500 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 500 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Endometrial Neoplasms | GlaxoSmithKlineAustraliaPtyLtd |
| Australia | (L01FF09) tislelizumab | Tevimbra 100 mg/10 mL injection, 10 mL vial | Solution concentrate for I.V. infusion 100 mg in 10 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Esophageal Squamous Cell Carcinoma;Carcinoma, Non-Small-Cell Lung;Small Cell Lung Carcinoma;Nasopharyngeal Carcinoma;Stomach Neoplasms | BEONEMEDICINESAUSPTYLTD |
| Australia | (L01FF13) toripalimab | Zytorvi 240 mg/6 mL injection, 6 mL vial | Solution concentrate for I.V. infusion 240 mg in 6 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
n/a | DrReddysLaboratories(Australia)PtyLtd |
| Australia | (L01FG01) bevacizumab | Abevmy 100 mg/4 mL injection, 4 mL vial | Solution for I.V. infusion 100 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | SandozPtyLtd |
| Australia | (L01FG01) bevacizumab | Abevmy 400 mg/16 mL injection, 16 mL vial | Solution for I.V. infusion 400 mg in 16 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | SandozPtyLtd |
| Australia | (L01FG01) bevacizumab | Mvasi 100 mg/4 mL injection, 4 mL vial | Solution for I.V. infusion 100 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AmgenAustraliaPtyLimited |
| Australia | (L01FG01) bevacizumab | Mvasi 400 mg/16 mL injection, 16 mL vial | Solution for I.V. infusion 400 mg in 16 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell;Peritoneal Neoplasms;Ovarian Neoplasms;Breast Neoplasms;Carcinoma, Non-Small-Cell Lung;Fallopian Tube Neoplasms | AmgenAustraliaPtyLimited |
| Australia | (L01FG01) bevacizumab | Vegzelma 100 mg/4 mL injection, 4 mL vial | Solution for I.V. infusion 100 mg in 4 mL, 1 pcs | Retail price without vat |
$0-0 |
$0-0 |
Colorectal Neoplasms;Breast Neoplasms;Ovarian Neoplasms;Fallopian Tube Neoplasms;Peritoneal Neoplasms;Carcinoma, Non-Small-Cell Lung;Carcinoma, Renal Cell;Uterine Cervical Neoplasms | CelltrionHealthcareAustraliaPtyLtd |
Pages
